Roivant Sciences Ltd.(NasdaqGS:ROIV) added to S&P 400
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 USD | +1.50% | +2.59% | +2.40% |
Apr. 05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
Apr. 04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.40% | 9.27B | |
+35.01% | 709B | |
+31.10% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+15.00% | 239B | |
+9.36% | 211B | |
-3.97% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd.(NasdaqGS: ROIV) added to S&P 400